MONMOUTH JUNCTION, NJ–(Marketwired – March 16, 2015) – DiamiR, LLC, a developer of innovative diagnostic tests for neurodegenerative and other diseases, announced today that the National Institute on Aging (NIA) of the National Institutes of Health (NIH) has awarded DiamiR a Small Business Innovation Research (SBIR) grant to support further validation and development of the company’s targeted diagnostic technology based on the analysis of brain-enriched microRNA biomarkers in plasma for early detection of Alzheimer’s disease and Mild Cognitive Impairment (MCI).